| An SI Board Since October 2010 |
| Posts |
SubjectMarks |
Bans |
Symbol |
| 0 |
1 |
0
|
HBRM |
|
Herborium Group, Inc., (Pink HBRM): focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium harvests its therapeutic candidates from Traditional Chinese Medicine and utilizes Western regulatory, clinical and marketing strategies to successfully introduce the products into Western markets.
Website: herborium.com
|
|
|
